Introduction
============

The chiral 1,3-diol structure is widespread in a broad spectrum of natural products \[[@R1]--[@R2]\]. (3*R*)-β-Hydroxy-δ-lactone or its open-ring equivalent (3*R*)-*syn*-3,5-dihydroxypentanoic acid, is a common structure in naturally occurring mevastatin (or compactin), lovastatin or closely related statins, and synthetic statins. Either the *syn* or *anti*-1,3-diol could be prepared from enantiomerically pure β-hydroxy ketones through β-hydroxy-directed carbonyl reduction following Evans' \[[@R3]\] or Prasad's \[[@R4]--[@R11]\] method. The Narasaka--Prasad reduction of a δ-hydroxy-β*-*keto esters derived from β-hydroxy esters \[[@R12]--[@R23]\] is widely used to prepare *tert*-butyl (3*R*)-3,5-*O*-isopropylidene-3,5-dihydroxyhexanoate ([Scheme 1](#C1){ref-type="fig"}) \[[@R24]--[@R37]\], which is a building block for synthetic statins \[[@R38]--[@R41]\], though enzymatic syntheses \[[@R42]--[@R48]\] of the chiral β-hydroxy-δ-lactone moiety or its equivalents, pioneered by Wong \[[@R42]\], is equally competitive. Here, we report the preparations of *tert*-butyl (3*S*,5*R*)-6-hydroxy-3,5-*O*-isopropylidene-3,5-dihydroxyhexanoate and related *syn*-1,3-diol analogs from a chiral 2-isoxazoline ([Scheme 1](#C1){ref-type="fig"}). This work is part of our continuous efforts in asymmetric syntheses and applications of chiral 2-isoxazolines \[[@R49]--[@R51]\].

![Accesses to *tert*-butyl 3,5-*O*-isopropylidene-3,5-dihydroxyhexanoates. (a) Previous methods using Claisen condensation. (b) Our new method using cycloaddition.](Beilstein_J_Org_Chem-15-1840-g002){#C1}

Results and Discussion
======================

Our synthesis commenced with a chiral 3,5-disubstituted-2-isoxazoline **3** or **4**, which were prepared from silyl nitronate through an asymmetric 1,3-dipolar cycloaddition developed in our lab ([Table 1](#T1){ref-type="table"}) \[[@R49]\]. The synthesis of the triisopropylsilyl nitronate was initially attempted starting with 3-nitropropionic acid methyl ester but no desired product was observed. However, switching to 3-nitropropanol, protected as the THP ether, succeeded to prepare the required triisopropylsilyl nitronate. Then, the catalytic asymmetric cycloaddition gave the 2-isoxazolidine cycloadduct **1** in a high yield. In the light of our previous ligand screening results \[[@R49]\], two bisoxazolines with an isopropyl (ligand B) or *tert*-butyl group (ligand A) were tested. Optimization of the conditions established that 26 mol % of ligand B together with 20 mol % Cu(OTf)~2~ in anhydrous CH~2~Cl~2~ catalyzed the cycloaddition between *N*-acryloyl-1,3-oxazolidin-2-one and the silyl nitronate at −50 °C to give **1** in 95% isolated yield, which subsequently generated 3,5-disubstituted isoxazoline **4** in 80% ee. Decreasing the amount of the chiral Lewis acid catalyst led to a decrease of both the ee and the yield. Desilylation of the 2-isoxazolidine **1** was effected in CHCl~3~ using catalytic amounts of *p*-toluenesulfonic acid (PTSA). Though the yield of the in situ-generated 2-isoxazoline **2** bearing the 1,3-oxazolidin-2-one auxiliary was perfect, purification of **2** by silica gel chromatography was problematic due to decomposition. No pure product was isolated from crude **2** by chromatography on silica gel. Decomposition occured to a compound similar to **2**, in which the 3-substituent was CH~2~OH \[[@R49]\]. To overcome this problem, the crude reaction mixture containing **2** and PTSA was concentrated before excess Et~3~N was added followed by CH~3~OH as the solvent. These operations removed the 1,3-oxazolidin-2-one auxiliary while preserving the THP group, and afforded the corresponding methyl ester **3** ([Table 1](#T1){ref-type="table"}), which was stable and could be subjected to silica gel chromatography. Compound **4** was used to determine the stereoselectivity of the cycloaddition step as well as for oxidation.

###### 

Optimization of the conditions for the asymmetric cycloaddition.

  -------------------------------------------- -------- ------------ ---------- ------------------- ----------------
  ![](Beilstein_J_Org_Chem-15-1840-i001.jpg)                                                        
                                                                                                    
  Entry                                        Ligand   x mol % Cu   *T* (°C)   Yield (%) (**1**)   ee (%) (**4**)
                                                                                                    
  1                                            A        10           −50        25                  18
  2                                            A        20           −50        75                  72
  3                                            B        10           −50        70                  66
  4                                            B        20           −50        95                  80
  5                                            B        20           −40        78                  78
  6                                            B        20           −60        84                  80
  -------------------------------------------- -------- ------------ ---------- ------------------- ----------------
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Oxidation of the 2-isoxazoline **4** with Jones' reagent gave a complicated mixture, in which the desired carboxylic acid was not observed ([Scheme 2](#C2){ref-type="fig"}). The stepwise oxidation of the free hydroxy to the carboxy group via intermediary aldehyde was then examined. Swern or pyridinium chlorochromate (PCC) oxidation of **4** also gave a complicated mixture without the desired aldehyde detected. These failed reactions indicated that the 2-isoxazoline moiety could not survive oxidation conditions. Based on this assumption, the corresponding silyl nitronate from 3-nitropropanal or its acetal were not tried for cycloaddition.

![Attempted oxidations of **4**.](Beilstein_J_Org_Chem-15-1840-g003){#C2}

We then set to liberate the β-hydroxy ketone synthon by ring opening of the isoxazoline **3** ([Scheme 3](#C3){ref-type="fig"}). Raney-Ni-catalyzed hydrogenolysis in the presence of boronic acid had been widely utilized to disconnect the N--O bond as well as to hydrolyze the resulting imine into a ketone \[[@R52]\]. We applied this method to deprotect the isoxazoline **3**. However, the desired β-hydroxy ketone was never obtained. In one instance, the methyl ketone from a retro-aldol reaction of the desired β-hydroxy ketone was observed. In our experience, the hydrogenolysis of a 2-isoxazoline having a 5-ester group was troublesome. Thus, the 5-ester group was reduced with NaBH~4~ to give **5**. The hydroxy group was subsequently protected with benzoyl ([Scheme 3](#C3){ref-type="fig"}), which also worked as a chromophore facilitating HPLC analysis. Afterwards, we tried oxidations once again. After removal of THP from **6**, the resulting compound **6\'** was subjected to oxidation with various reagents ([Scheme 4](#C4){ref-type="fig"}) \[[@R53]--[@R55]\]. The expected carboxylic acid or aldehyde was not observed, which further verified the intolerance exemplified in [Scheme 2](#C2){ref-type="fig"}. These results prompted us to try the oxidation in a later stage.

![Preparations of **16** and related *syn*-1,3-diol compounds.](Beilstein_J_Org_Chem-15-1840-g004){#C3}

![Attempted oxidations of **6\'**.](Beilstein_J_Org_Chem-15-1840-g005){#C4}

When **6** was subjected to Raney-Ni-catalyzed hydrogenolysis, the desired β-hydroxy ketone **7** was obtained in 85% yield ([Scheme 3](#C3){ref-type="fig"}). Under the weakly acidic conditions, the THP group survived. Next, a Narasaka--Prasad reduction \[[@R4]--[@R11]\] of **7** using Et~2~BOMe and NaBH~4~ at −78 °C gave stable ethylboronate **8** in 96% yield. Several ethylboronate compounds have been reported \[[@R9]--[@R11] [@R56]--[@R62]\]. From **8** to **9**, no H~2~O~2~ treatment was necessary. Rotary evaporation of **8** with CH~3~OH at ca. 40 °C easily removed the ethylborane group. Removal of THP in **9** delivered a 1,3,5-trihydroxy compound **10**. In another way, **10** could be prepared by treating **8** with PTSA in CH~3~OH at rt. NMR spectra of **8**--**10** exhibited only one set of signals corresponding to the *syn*-dihydroxy products, indicating an extra high diastereoselectivity (*syn*:*anti* \>99:1) during the reduction. To unambiguously determine the diastereomeric ratio, the *anti*-1,3-diol corresponding to **10** was prepared from **7** by RuCl~3~--PPh~3~-catalyzed hydrogenation \[[@R63]--[@R64]\]. However, the two diastereomers had identical proton NMR spectra.

The terminal hydroxy group of **10** was protected with TBS \[[@R65]--[@R69]\] and the *syn*-hydroxy groups subjected to acetonization using PTSA and dimethoxypropane (DMP) to give **12** in 86% total yield \[[@R70]\]. Treatment of **12** with TBAF again liberated the terminal hydroxy group for further oxidation. RuCl~3~-catalyzed oxidation of **13** with NaIO~4~ yielded the carboxylic acid **14** in 86% yield \[[@R70]\], which was reacted with Boc~2~O to get the *tert*-butyl ester **15** \[[@R26],[@R43],[@R71]\]. The ee of **15** was determined as 74%. The racemic sample of **15** was prepared from racemic diethyl malate following known methods \[[@R26]--[@R27]\]. Finally, K~2~CO~3~-catalyzed methanolysis gave **16** in 87% yield \[[@R26]--[@R27]\]. The absolute stereochemistry of **16** was confirmed by crystal structure analysis \[[@R72]\] and the specific rotation \[[@R28]\] of **17**. Centimeter-long prismatic single crystals of **17** were obtained by slow evaporation of a petroleum solution.

Starting from **9**, we tested several reactions in order to selectively protect the internal hydroxy groups ([Scheme 5](#C5){ref-type="fig"}). Though not fruitful, these results deserve some comments. The PTSA-catalyzed acetonization of **9** using 2.0 equiv DMP gave the acetonide **18** in a quantitative yield. Treating **18** with a catalytic amount of PTSA in methanol gave **10**, with the protecting groups removed except benzoyl. PTSA-catalyzed acetonization of **10** using 2.0 equiv DMP gave a mixture of two acetonides **19** and **13**, which are separable by silica gel chromatography ([Scheme 5](#C5){ref-type="fig"}). In another trial ([Scheme 5](#C5){ref-type="fig"}), acylation of the two hydroxy groups in **9** yielded **20** in a quantitative yield. PTSA-catalyzed removal of THP in **20** in methanol did occur. However, concomitant monodeacylation as well as further an acyl-transfer reaction also took place, resulting in a mixture. These results indicated THP, isopropylidene or Ac protection to primary or secondary hydroxy groups did not well tolerate PTSA-catalyzed methanolysis.

![Attempted selective protections of internal 1,3-hydroxy groups: (a) acetonizations of 1,3-diols; (b) removal of co-existing Ac and THP on hydroxy groups.](Beilstein_J_Org_Chem-15-1840-g006){#C5}

Conclusion
==========

In conclusion, we synthesized *tert*-butyl (3*S*,5*R*)-6-hydroxy-3,5-*O*-isopropylidene-3,5-dihydroxyhexanoate (**16**), which is enantiomeric to a key intermediate for atorvastatin, from a chiral 2-isoxazoline (**3**). The β-hydroxy ketone **7** obtained from **3** could be easily converted into several *syn*-1,3-diol analogs, demonstrating the usefulness of chiral 2-isoxazolines.

Experimental
============

**1**: To a dry Schlenk tube were added Cu(OTf)~2~ (144 mg, 0.4 mmol), chiral bisoxazoline B (139 mg, 0.52 mmol) and anhydrous CH~2~Cl~2~ (4 mL) under N~2~. After stirring at room temperature for 2 h, a clear solution had formed, which was cooled to −50 °C and *N*-acryloyl-1,3-oxazolidin-2-one (282 mg, 2 mmol) was added. After stirring for 30 min, a solution of the silyl nitronate (3.0 mmol) in anhydrous CH~2~Cl~2~ (6 mL) was added. The mixture was stirred for 8 h at −50 °C and monitored by TLC. After the reaction was completed, the product was purified by silica gel chromatography. Yellow oil (923 mg, 95% yield); *R* ~f~ 0.40 (1:1 hexanes/AcOEt); ^1^H NMR (400 MHz, CDCl~3~) δ 5.77--5.74 (m, 1H, CH~2~C*H*O), 4.53 (s, 1H, OC*H*O), 4.44 (t, *J* = 8.0 Hz, 2H, C*H* ~2~O), 4.03--3.99 (m, 2H, C*H* ~2~O), 3.79--3.74 (m, 2H, OC*H* ~2~CH~2~), 3.47--3.37 (m, 3H, NC*H* and NC*H* ~2~), 2.75--2.66 (m, 1H, CHC*H* ~2~CH), 2.31--2.27 (m, 1H, CHC*H* ~2~CH), 2.17--2.12 (m, 1H, C*H* ~2~CH~2~), 1.84--1.79 (m, 2H, CH~2~C*H* ~2~ and CH~2~CH~2~C*H* ~2~), 1.68--1.49 (m, 6H, C*H* ~2~C*H* ~2~C*H* ~2~), 1.24--1.15 (m, 3H, SiCH), 1.07--1.01 (m, 18H, SiCH(C*H* ~3~)~2~); ^13^C NMR (100 MHz, CDCl~3~) δ 170.8, 153.1, 98.9, 98.9, 77.4, 77.2, 69.9, 69.8, 65.2, 62.8, 62.5, 62.3, 42.6, 35.6, 35.5, 30.7, 30.6, 29.9, 29.8, 25.5, 19.6, 19.5, 18.1, 18.0, 12.2; IR (cm^−1^): 3544, 2942, 2867, 2725, 2249, 1780, 1704, 1464, 1386, 1275, 1133, 1035, 883, 806, 677; ESIMS (*m*/*z*): \[M + Na\]^+^ calcd for C~23~H~42~N~2~O~7~Si, 509.2659; found, 509.2659.

**3**: To a solution of **1** (0.86 g, 1.78 mmol) in CHCl~3~ (15 mL) was added PTSA (31 mg, 0.178 mmol) at 0 °C. The mixture was allowed to warm to room temperature and stirred until complete consumption of the starting material (0.5 h). Vacuum was applied to remove the solvent before Et~3~N (5 mL) was added. After stirring for 5 min, methanol (30 mL) was added and the mixture was stirred overnight at room temperature. The crude product was purified by column chromatography. Yellow oil (0.41 g, 89% yield); *R* ~f~ 0.42 (1:1 hexanes/AcOEt); ^1^H NMR (400 MHz, CDCl~3~) δ 4.92--4.87 (m, 1H, OC*H*CO), 4.51--4.50 (m, 1H, OC*H*O), 3.88--3.82 (m, 1H, C*H* ~2~O), 3.75--3.71 (m, 1H, C*H* ~2~O), 3.68 (s, 3H, C*H* ~3~), 3.56--3.50 (m, 1H, C*H* ~2~O), 3.42--3.39 (m, 1H, C*H* ~2~O), 3.24--3.31 (m, 1H, CHC*H* ~2~CH), 2.62--2.54 (m, 1H, CH~2~C*H* ~2~CH), 1.74--1.44 (m, 6H, C*H* ~2~C*H* ~2~C*H* ~2~); ^13^C NMR (100 MHz, CDCl~3~) δ 171.0, 156.9, 99.0, 98.9, 64.4, 64.3, 62.5, 62.4, 52.6, 41.6, 30.6, 27.9, 25.4, 19.6, 19.5; IR (cm^−1^): 3481, 2950, 2873, 2852, 2657, 1756, 1738, 1734, 1628, 1456, 1436, 1367, 1354, 1201, 1134, 1034, 869, 814, 752, 740; ESIMS (*m*/*z*): \[M + H\]^+^ calcd for C~12~H~19~NO~5~, 258.1341; found, 258.1340.
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